Topicals with evidence, the actives that don't have it, peels, lasers for skin, and the conditions that resist all of it.
A clinical review of Microtox (MesoBotox). Discover how intradermal neuromodulator injections target receptors to reduce pore size and sebum, and review clinical trials.
An evidence-based clinical review of NAD+ IV therapy, analyzing the 2025 FDA Class I recall of GenoGenix lots, endotoxin contamination risks, and human clinical trial…
Pseudofolliculitis barbae affects up to 83% of Black men who shave. We lay out the evidence ladder from shaving cessation to 1064 nm Nd:YAG laser hair removal for…
Keloids and hypertrophic scars are raised scars that overgrow the wound. The evidence ladder: intralesional triamcinolone, 5-FU, cryotherapy, PDL, radiation, and why…
Sclerotherapy is the gold standard for spider and leg reticular veins, using FDA-approved sclerosants Asclera and Sotradecol. The evidence, foam vs liquid, Nd:YAG laser,…
Alopecia areata is autoimmune hair loss, not pattern baldness. Three FDA-approved JAK inhibitors (Olumiant, Litfulo, Leqselvi) finally treat severe disease — with real…
Vitiligo is an autoimmune loss of pigment. The 2022 FDA approval of Opzelura (ruxolitinib) made it the first repigmentation drug — used alongside NB-UVB, excimer laser,…
Rosacea is treated by matching therapy to the feature that bothers you — redness, bumps, visible vessels, thickened skin, or eye symptoms. The evidence ladder for each,…
Sun spots (solar lentigines) are UV-driven pigment that fades well — once melanoma is ruled out. The evidence ladder: sunscreen, topicals, cryotherapy, peels, IPL, and…
Stretch marks affect most pregnant people and many teens. An evidence ladder — topicals, microneedling, RF, fractional laser — for early red vs mature white marks, with…